OneMedNet Co. (NASDAQ:ONMD – Get Free Report) was the recipient of a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 71,500 shares, a decrease of 36.1% from the February 13th total of 111,900 shares. Based on an average daily volume of 138,600 shares, the short-interest ratio is currently 0.5 days. Approximately 0.5% of the shares of the company are sold short.
Institutional Investors Weigh In On OneMedNet
A number of institutional investors and hedge funds have recently added to or reduced their stakes in ONMD. Geode Capital Management LLC raised its position in shares of OneMedNet by 49.6% during the fourth quarter. Geode Capital Management LLC now owns 152,937 shares of the company’s stock valued at $208,000 after buying an additional 50,690 shares during the last quarter. Virtu Financial LLC raised its position in shares of OneMedNet by 160.1% during the fourth quarter. Virtu Financial LLC now owns 32,389 shares of the company’s stock valued at $44,000 after buying an additional 19,938 shares during the last quarter. Finally, XTX Topco Ltd raised its position in shares of OneMedNet by 280.3% during the third quarter. XTX Topco Ltd now owns 41,683 shares of the company’s stock valued at $25,000 after buying an additional 30,723 shares during the last quarter. Institutional investors own 0.95% of the company’s stock.
OneMedNet Price Performance
Shares of NASDAQ:ONMD traded down $0.04 during trading on Monday, hitting $0.66. The company’s stock had a trading volume of 54,167 shares, compared to its average volume of 2,036,490. The company has a 50-day moving average of $1.00 and a 200-day moving average of $0.93. OneMedNet has a 12 month low of $0.46 and a 12 month high of $3.37.
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.
See Also
- Five stocks we like better than OneMedNet
- The Role Economic Reports Play in a Successful Investment Strategy
- Can TikTok Stock Picks Really Make You Rich?
- What Are Dividend Champions? How to Invest in the Champions
- The “Quality” Rotation: Back to Basics Investing
- What is a buyback in stocks? A comprehensive guide for investors
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.